Protocol summary
-
Study aim
-
ِDeterminig the effectiveness of intravenous Dexamethasone on the incidence of nausea and vomiting after deep sedation, in upper GI endoscopy in pediatric patients
-
Design
-
Randomized, parallel group trial with blinded outcome assessment and postoperative care.
-
Settings and conduct
-
Based on the inclusion and exclusion criteria, 98 children aged 2 to 14, candidate for an elective upper GI endoscopy are selected, and after an informed consent is obtained from their parents, are randomly divided into 2 groups. In both groups standard monitoring devices will be installed. after preoxigenation with 100% O2, anesthesia is induced with 2.5 mg/kg thiopental and deepened with Sevoflurane. Preopertively, in the intervention group 0/1 mg/kg IV Dexamethasone and in the control, same volume of IV normal saline will be administered. Postoperatively, data on incidence of Nausea/vomiting and other outcomes will be collected in the recovery room, by an investigator who is blinded to the intervention allocation.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: All 2 to 14 year-old children, who are a candidate for an elective upper GI endoscopy, and whose parents have given an informed consent; Exclusion criteria: Patients with a history of hypersensitivity to the drugs studied, metabolic disease or diabetes, anatomical upper airway disorders, Patients diagnosed with behavioral disorders or currently taking psychiatric medication, patients who have previously undergone chemotherapy or have taken a sedative/hypnotic drug prior to endoscopy, Patients who are a candidate for an emergency endoscopy or whose operation is complicated and takes too long to be completed
-
Intervention groups
-
For intervention group 0/1 mg/kg IV Dexamethasone, and for the control, same volume of IV normal saline will be administered before operation.
-
Main outcome variables
-
Incidence of nausea/vomiting after endoscopy
General information
-
Reason for update
-
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20180929041173N1
Registration date:
2018-10-26, 1397/08/04
Registration timing:
prospective
Last update:
2019-09-20, 1398/06/29
Update count:
2
-
Registration date
-
2018-10-26, 1397/08/04
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2018-11-03, 1397/08/12
-
Expected recruitment end date
-
2018-11-13, 1397/08/22
-
Actual recruitment start date
-
2018-11-03, 1397/08/12
-
Actual recruitment end date
-
2018-11-21, 1397/08/30
-
Trial completion date
-
2018-11-21, 1397/08/30
-
Scientific title
-
Effectiveness of intravenous Dexamethasone on the incidence of nausea and vomiting after deep sedation, in upper GI endoscopy in pediatric patients
-
Public title
-
Antiemetic effect of Dexamethasone in pediatric endosocopy
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
All 2 to 14 year-old children, candidate for an elective upper GI endoscopy, according to the pediatric gastroenterologist diagnosis
Exclusion criteria:
Patients with a history of hypersensitivity to the drugs studied
Patients with a history of metabolic disease or diabetes
Patients with anatomical upper airway disorders
Patients diagnosed with behavioral disorders or currently taking psychiatric medication
Patients with a history of undergoing chemotherapy
Patients who have taken a sedative/hypnotic drug prior to endoscopy
Patients who are a candidate for an emergency endoscopy
Patients whose operation is complicated (e.g. by bleeding) and takes too long to be completed
Patients without a parental informed consent
-
Age
-
From 2 years old to 14 years old
-
Gender
-
Both
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Care provider
- Investigator
- Outcome assessor
-
Sample size
-
Target sample size:
98
Actual sample size reached:
98
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
A statistical computer program is used to make random block stratified individual assignments with user selected block sizes. The psuedonumber generator is a linear congruential algorithm of Park and Milller with Bays-Durham shuffling. The random sheets will be given directly to nurse administrating the drugs and neither the participants nor the researcher collecting the data will be informed of the method of drug allocation to patients.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
The randomly allocated list of patients will be given exclusively to the nurse administrating the drugs. Participants, gastroenterologist performing endoscopy, attending anesthesiologist, recovery nurse and the researcher collecting data will not be informed of the method of drug allocation to patients.
(The parents of participants will be thoroughly informed that this clinical trial uses a randomized method before giving consent)
-
Placebo
-
Used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2018-10-17, 1397/07/25
-
Ethics committee reference number
-
IR.TUMS.MEDICINE.REC.1397.505
Health conditions studied
1
-
Description of health condition studied
-
Post endoscopy nausea and vomiting
-
ICD-10 code
-
R11
-
ICD-10 code description
-
Nausea and vomiting
Primary outcomes
1
-
Description
-
incidence of nausea/vomiting
-
Timepoint
-
Recording the incidence of nausea/vomiting, evaluated during patients' stay in the post-anesthesia recovery room
-
Method of measurement
-
Investigator evaluation and examination
Secondary outcomes
1
-
Description
-
Post anesthesia emergence delirium
-
Timepoint
-
Recording the highest score of patients on PAED sacle, during their stay in the post-anesthesia recovery room
-
Method of measurement
-
Pediatric Anesthesia Emergence Delirium (PAED) Scale
2
-
Description
-
incidence of bronchospasm/laryngospasm
-
Timepoint
-
Recording the incidence bronchospasm/laryngospasm, evaluated during patients' stay in the post-anesthesia recovery room
-
Method of measurement
-
Investigator evaluation and examination
3
-
Description
-
Time needed for patient recovery after endoscopy
-
Timepoint
-
Recording the time of patients stay in the post-anesthesia recovery room after endoscopy
-
Method of measurement
-
Subtracting the recorded time of entry to the recovery room, from the time the patient is eligible for transfer to the secondary recovery facilities
4
-
Description
-
Patients recovery state
-
Timepoint
-
Patients score on the Modified Aldrete scale is calculated and recorded at the time of entry to post-anesthesia recovery room, 5 minutes after entry, and at the time of discharge
-
Method of measurement
-
Modified Aldrete scale
Intervention groups
1
-
Description
-
Intervention group: After anesthesia is induced and deepened, 0/1 mg/(kg of body weight) of Dexamethasone is administered to patients intravenously
-
Category
-
Treatment - Drugs
2
-
Description
-
Control group: After anesthesia is induced and deepened, same volume of normal saline is administered to patients intravenously
-
Category
-
Placebo
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Tehran University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Not applicable
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Not applicable
-
Analytic Code
-
Not applicable
-
Data Dictionary
-
Not applicable
Trial results
-
Please tick if results have been published
-
Yes
-
Summary result posting date
-
2019-09-20, 1398/06/29
-
Table of baseline comparison
-
-
Participant flow diagram
-
-
Table of variable outcomes' results
-
-
Table of adverse events
-
-
First publication date
-
2019-09-01, 1398/06/10
-
Abstract of published paper
-
Objectives: We aimed to evaluate the effect of a single dose of preoperative dexamethasone on postoperative nausea and vomiting (PONV), a frequent complication and a major cause of delayed recovery in pediatric upper gastrointestinal endoscopy (UGIE) under sedation.
Methods: In this double-blind randomized controlled study, 98 children aged 2 to 14, with American Society of Anesthesiologists status I to II, and undergoing elective UGIE with deep sedation were included and randomly assigned to 2 groups. Preoperatively, after anesthesia induction with sodium thiopental and maintenance with sevoflurane, patients in the intervention (n = 49) and control (n = 49) groups, respectively received 0.1 mg/kg i.v. dexamethasone and 2 cm3 i.v. 0.9% saline. Postoperatively, PONV incidence was measured as the primary outcome.
Results: PONV incidence was significantly less in dexamethasone group (8.2%) compared to the control group (26.5%) (difference = 18.3%, 95% confidence interval: 3.4%−33%, P = 0.016). For secondary outcomes, between-group differences were not statistically significant: incidence of bronchospasm or laryngospasm (both 4.1%, P = 1); emergence delirium assessed with Pediatric Anesthesia Emergence Delirium scale (5.9 ± 3.4 vs 5.7 ± 3.2, P = 0.751); Modified Aldrete score at 0 minutes (9.4 ± 0.8 vs 9.3 ± 0.9, P = 0.909) and at 5 minutes (9.5 ± 0.7 vs 9.4 ± 0.9, P = 0.527); and recovery time (21.1 ± 6.6 vs 23.4 ± 8.6 minutes, P = 0.130).
Conclusions: A single preoperative dose of i.v. dexamethasone reduces PONV in children undergoing elective UGIE with deep sedation, but has no significant effect on the patient recovery time or the incidence of postoperative bronchospasm or laryngospasm and emergence delirium.